Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026)
Perspective Therapeutics (CATX) reported Receivables - Net of $58000.0 for Q1 2026, down 25.64% on a YoY basis from $78000.0 in Q1 2025, and up 866.67% sequentially from $6000.0 in Q4 2025.
Perspective Therapeutics (CATX) Receivables - Net (2011 - 2026) Analysis & Trends
Perspective Therapeutics (CATX) has 16 years of Receivables - Net data on file, last reported at $58000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net fell 25.64% year-over-year to $58000.0; the trailing twelve-month figure through Mar 2026 stood at $58000.0 (down 25.64% YoY), and the FY2025 full-year result was $6000.0, down 94.83% from the prior year.
- Receivables - Net grew to $58000.0 in Q1 2026, from $6000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $2.1 million in Q1 2022 to a low of $6000.0 in Q4 2025.
- A 5-year average of $806882.4 and a median of $999000.0 in 2024 frame the typical range for Receivables - Net.
- Peak annual rise in Receivables - Net reached 58.45% in 2025, while the deepest fall reached 94.83% in 2025.
- Tracing CATX's Receivables - Net over 5 years: stood at $1.4 million in 2022, then retreated by 14.53% to $1.2 million in 2023, then sank by 90.04% to $116000.0 in 2024, then slumped by 94.83% to $6000.0 in 2025, then jumped by 866.67% to $58000.0 in 2026.
- Business Quant data shows CATX's Receivables - Net at $58000.0 in Q1 2026, $6000.0 in Q4 2025, and $179000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Perspective Therapeutics | 146.05 Mn | 146.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Mar 31, 2025 | 78,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Mar 31, 2024 | 999,000.00 |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |